Myectomy for hypertrophic obstructive cardiomyopathy after failed alcohol septal ablation: Clinicopathological correlations

Canadian Journal of Cardiology

Volumn 17, Issue 2, 2001, Pages 197-202

  Arrazaghi, A A ^a   Butany, J W ^a   Williams, W G ^a   Wigle, D E ^a   Rakowski, H ^a  

^a TORONTO GENERAL HOSPITAL   (Canada)

Author keywords

Ablation; Alcohol; Cardiomyopathy; Pathology

Indexed keywords

ALCOHOL; METOPROLOL TARTRATE; VERAPAMIL;

ADULT; ARTICLE; CASE REPORT; CATHETER; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; ECHOCARDIOGRAPHY; HEART LEFT VENTRICLE OUTFLOW TRACT OBSTRUCTION; HEART VENTRICLE SEPTUM; HUMAN; HUMAN TISSUE; HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY; IMAGE QUALITY; MALE; MORPHOLOGY; MUSCLE RESECTION; NEUROSURGERY; PRESSURE GRADIENT; SCAR FORMATION; TREATMENT FAILURE;

CARDIAC SURGICAL PROCEDURES; CARDIOMYOPATHY, HYPERTROPHIC; ECHOCARDIOGRAPHY, TRANSESOPHAGEAL; ETHANOL; HEART SEPTUM; HUMANS; INJECTIONS; MALE; MIDDLE AGED; SOLVENTS; TREATMENT FAILURE;

EID: 0035056742     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Idiopathic hypertrophic subaortic stenosis: A description of the disease based upon analysis of 64 patients
2. Hypertrophic cardiomyopathy: Interrelations of clinical manifestations, pathophysiology, and therapy - Part 1
3. Hypertrophic cardiomyopathy: Interrelations of clinical manifestations, pathophysiology, and therapy - Part 2
4. Asymmetrical hypertrophy of the heart in young adults
5. Hypertrophic cardiomyopathy: A discussion of nomenclature
6. Hypertrophic cardiomyopathy: The importance of the site and the extent of hypertrophy - A review
7. Phenotypic spectrum and patterns of left ventricular hypertrophy in hypertrophic cardiomyopathy: Morphologic observations and significance as assessed by two-dimensional echocardiography in 600 patients
8. The management of hypertrophic cardiomyopathy
9. Prevalence of hypertrophic cardiomyopathy in a general population of young adults: Echocardiographic analysis of 4111 subjects in the CARDIA Study
10. Prevalence of hypertrophic cardiomyopathy in an outpatient population referred for echocardiographic study
11. Hypertrophic cardiomyopathy: Clinical spectrum and treatment
12. Verapamil therapy: A new approach to the pharmacological treatment of hypertrophic cardiomyopathy: III. Effects of long-term administration
13. Symptomatic status and prognosis of patients after operation of hypertrophic obstructive cardiomyopathy: Efficacy of ventricular septal myotomy and myectomy
14. Long-term results of dual-chamber (DDD) pacing in obstructive hypertrophic cardiomyopathy. Evidence for progressive symptomatic and hemodynamic improvement and reduction of left ventricular hypertrophy
15. Dual-chamber pacing for hypertrophic cardiomyopathy: A randomized, double-blind, crossover trial
16. Unchanged hemodynamics in DDD pacemaker stimulation because of hypertrophic cardiomyopathy in subjective clinical improvement
17. Induction of subaortic septal ischaemia to reduce obstruction in hypertrophic obstructive cardiomyopathy: Studies to develop a new catheter-based concept of treatment
18. Relief of obstruction in hypertrophic cardiomyopathy by transient occlusion of the first septal branch of the left coronary artery
19. Non-surgical myocardial reduction for hypertrophic obstructive cardiomyopathy
20. Nonsurgical septal reduction for hypertrophic obstructive cardiomyopathy: Outcome in the first series of patients
21. Hypertropic obstructive cardiomyopathy: Alternative therapeutic options
22. Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: Acute results and 3-month follow-up in 25 patients
23. Hypertrophic cardiomyopathy
24. Patterns and significance of distribution of left ventricular hypertrophy in hypertrophic cardiomyopathy: A wide angle, two dimensional echocardiographic study of 125 patients
25. Hypertrophic cardiomyopathy with extreme increase in left ventricular wall thickness: Functional and morphologic features and clinical significance
26. Anatomic and light microscopic characterization of hypertrophic obstructive and non-obstructive cardiomyopathy
27. Myocardial ultrastructure in idiopathic hypertrophic subaortic stenosis: A study of operatively excised left ventricular outflow tract muscle in 14 patients
28. Histopathological specificity of hypertrophic obstructive cardiomyopathy: Myocardial fibre disarray and myocardial fibrosis
29. Asymmetric septal hypertrophy and myocardial fiber disarray: Features of normal, developing, and malformed hearts
30. Isometric cardiac contraction: A possible cause of the disorganized myocardial pattern of idiopathic hypertrophic subaortic stenosis
31. The current status of myocardial disarray in hypertrophic cardiomyopathy
32. Regional myocyte hypertrophy and increased interstitial myocardial fibrosis in hypertrophic cardiomyopathy
33. Intramural ('small vessel') coronary artery disease in hypertrophic cardiomyopathy
34. Acute and long-term results after transcoronary ablation of septal hypertrophy (TASH). Catheter interventional treatment for hypertrophic obstructive cardiomyopathy